LINC01572

ncRNA information

ncRNA name

LINC01572

Specific or universal ncRNAs

Specific ncRNAs

Class

Long noncoding RNA

Biomarker

None

Biomarker application

Upstream regulatory factors

Not available

Downstream target

miR-497-5p

Cancer information

Cancer name

Gastric Cancer

Cancer site

qRT-PCR,Western blot,Dual-luciferase assay

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Down

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Up

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

LINC01572 Regulates Cisplatin Resistance in Gastric Cancer Cells by Mediating miR-497-5p

Tissue resource

tissues samples from cisplatin-resistant and cisplatin-sensitive patients

normal gastric mucosal cell lines GES-1

parental gastric cancer cell lines BGC823

parental gastric cancer cell lines SGC7901

gastric cancer cisplatin-resistant cell lines BGC823/DDP

gastric cancer cisplatin-resistant cell lines SGC7901/DDP

Experiment

None


Institute

Cangzhou Central Hospital

American Type Culture Collection

Country

China

United States

Continent

Asia

North Amercian